Voyageur Pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) announced that it has raised $687,099 through the exercise of 5,725,829 share purchase warrants.
“We sincerely appreciate the support our existing investors have placed in us,” Voyageur CEO Brent Willis said in a statement.
“The warrant exercises will give Voyageur added flexibility in achieving its goals to become a leader in the radiology drug market.”
The warrant exercises resulted in the issuance of an equal number of common shares, helping the company streamline its capitalization table.
The warrants were part of a second closing of a private placement of units that Voyageur conducted in January 2023. This placement originally issued a total of 14,570,764 warrants, of which 8,844,935 expired unexercised.
In addition, another 2,571,369 warrants expired in December 2024, further optimizing the company's capital structure.